Canndoc, an Israeli manufacturer of medical-grade hashish, on Sunday obtained a cargo of 250 kilos of dried whole hashish flowers that it says will help alleviate a scarcity in Israel.
Canndoc, a subsidiary of InterCure Ltd, last week signed a strategic cooperation settlement with Canada’s Tilray Inc. for the export and import of medical cannabis.
The corporate stated it was the primary ever commercial cargo of medical-grade hashish into Israel. It arrived from Tilray’s manufacturing plant in Portugal.
Canndoc has a deal to import as much as 2.5 metric tonnes of medical hashish from Tilray. The corporate, like its peers, aims to export medical marijuana as soon as Israeli rules are in place. The federal government has already permitted cannabis exports.
Barak estimates Canndoc will be capable to begin exporting within 12 months, as soon as there is ample production for Israelis. Under the deal, Canndoc will promote as much as 5 tonnes of medical hashish to Tilray.
Canndoc cited Health Ministry data that Israel’s market for medical marijuana will reach 100,000 by the end of 2020.
The Israeli government is keenly taking steps to current medical marijuana shortage.